Paid Clinical Trials in Asheville, NC
As of September 2026, 90 paid clinical trials are recruiting in Asheville, North Carolina. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Asheville offers studies at sites including Mission Hospital for conditions such as Heart Failure, Acute Myeloid Leukemia, Geographic Atrophy, Graves' Disease. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Asheville
Trials by drug in Asheville
Filter results
Newly added in Asheville
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
86 clinical trials
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
Study of EVO756 in Adults With Migraine
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
RevCore for In Stent Thrombosis
The ArtixASCEND Study
Exactech Shoulder Post Market Clinical Follow-up Study
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material
Virtue® SAB in the Treatment of Coronary ISR Trial
Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System
Top Research Study Locations in Asheville
Researchers run research studies in Asheville, NC at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Mission Hospital | Heart Failure, Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia | 26 |
| AdventHealth Infusion Center Asheville | Malignant Solid Neoplasm, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 5 |
| Mission Health | Aortic Stenosis, Aortic Valve Disease, Aortic Valve Stenosis | 5 |
| Messino Cancer Center | CRC (Colorectal Cancer), Melanoma, Metastatic Castration-Resistant Prostate Cancer | 4 |
| Asheville Clinical Research | Diabetic Peripheral Neuropathic Pain, Graves' Disease, Type 1 Diabetes | 4 |
| Asheville VA Medical Center, Asheville, NC | Alcohol Use Disorder, Chronic Low Back Pain, Comorbid Post-Traumatic Stress Disorder and OCD | 3 |
| Hope Women's Cancer Centers-Asheville | Ovarian Carcinoma, Stage I Breast Cancer | 2 |
| Woolfson Eye Institute | Forme Fruste Keratoconus (FFK), Keratoconus, Down Syndrome (DS) | 2 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis | 1 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 1 |
| Allergy Partners Clinical Research | Asthma | 1 |
| Allergy Partners Of West NC | Chronic Spontaneous Urticaria (CSU) | 1 |
| Allergy Partners of Western North Carolina | Asthma | 1 |
| Asheville Cardiology Associates | Heart Failure With Mildly Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction, Obesity | 1 |
| Asheville Cardiology Associates Research Department | Percutaneous Coronary Intervention, Peripheral Endovascular Intervention | 1 |
| Asheville Eye Associates - Regional Medical Park | Dry Eye Disease (DED) | 1 |
| Asheville Eye Associates - Retina Division | Geographic Atrophy | 1 |
| Asheville Eye Associates - Western Carolina Retinal Associates | Geographic Atrophy, Macular Degeneration | 1 |
| Asheville Eye Associates, Retina Division | Age-Related Macular Degeneration, Choroidal Neovascularization, Macular Degeneration | 1 |
| Asheville Neurology | Parkinson's Disease | 1 |
| Asheville Neurology Specialists | Epilepsy, Focal Epilepsy, Focal Seizure | 1 |
| Asheville Neurology Specialists, P.A. | Parkinson Disease | 1 |
| Asheville Neurology Specialists, Pa | Migraine | 1 |
| Asheville VA-Charles George VA Medical Center | Cardiovascular Diseases, Cognitive Impairment, Mild, Dementia | 1 |
| Asheville, North Carolina | Branch Retinal Vein Occlusion (BRVO), Neovascular Age-Related Macular Degeneration (NVAMD) | 1 |
Active & Upcoming Studies in Asheville (2026)
Recruiting trials in Asheville grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (23 active studies)
- A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014) · Phase 3 · Merck Sharp & Dohme LLC
- A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer · Phase 3 · Incyte Corporation
Cardiovascular (17 active studies)
- Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI) · Supira Medical
- Virtue® SAB in the Treatment of Coronary ISR Trial · Orchestra BioMed, Inc
Diabetes & metabolic (6 active studies)
- Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes · Insulet Corporation
- SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes · Phase 2 · SAb Biotherapeutics, Inc.
Neurology & pain (6 active studies)
- Study of EVO756 in Adults With Migraine · Phase 2 · Evommune, Inc.
- Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1 · Phase 3 · Rapport Therapeutics Inc.
Eye & vision (6 active studies)
- An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease · Phase 2 · Dompé Farmaceutici S.p.A
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) · Phase 2, Phase 3 · EyeBiotech Ltd.
Mental health & behavior (1 active study)
Common conditions studied in Asheville
- Heart Failure (5 active studies)
- Acute Myeloid Leukemia (3 active studies)
- Geographic Atrophy (3 active studies)
- Graves' Disease (3 active studies)
- Malignant Solid Neoplasm (3 active studies)
- Acute Lymphoblastic Leukemia (2 active studies)
Leading research sponsors in Asheville
- Children's Oncology Group
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- VA Office of Research and Development
- AbbVie
Frequently asked questions
How many paid clinical trials are currently recruiting in Asheville?
There are approximately 90 recruiting clinical trials in Asheville, North Carolina listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Asheville pay participants?
Most recruiting trials in Asheville compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Asheville?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Asheville?
The most common conditions under active study in Asheville include Heart Failure (5), Acute Myeloid Leukemia (3), Geographic Atrophy (3), Graves' Disease (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Asheville?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Asheville on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Asheville?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Asheville?
Recruiting research sites in Asheville include Mission Hospital, AdventHealth Infusion Center Asheville, Mission Health, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Asheville right now?
The largest active categories in Asheville are Cancer & tumors (23), Cardiovascular (17), Diabetes & metabolic (6). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.